1 Department of Clinical Epidemiology, Biostatistics and Bioinformatics (KEBB), Academic Medical Centre (AMC), University of Amsterdam (UvA), Amsterdam, The Netherlands 2 Dutch Cochrane Centre (DCC), ...
Globally, drug regulators have approved statins for the prevention of cardiovascular disease (CVD), although their use in primary prevention has been controversial. A highly publicised debate has ...
Correspondence to Sir Iain Chalmers, James Lind Initiative, Summertown Pavilion, Middle Way, Oxford OX2 7LG, UK; ichalmers{at}jameslind.net We are surrounded by maelstroms of claims about the effects ...
Correspondence to Dr Elaine Lehane, Catherine McAuley School of Nursing and Midwifery, University College Cork, Cork T12 K8AF, Ireland; e.lehane{at}ucc.ie To highlight and advance clinical ...
Health technology assessment in India in the next decade: reflections on a vision for its path to maturity and impact ...
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be ...
Correspondence to Dr Eden S N McCaffrey, Deparmtent of Psychiatry, Alberta Health Services, University of Calgary, Calgary, AB T2E5 K4, Canada; eden.mccaffrey{at}ahs.ca We tested the hypothesis that a ...
Correspondence to Dr Jian-peng Huang, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China; hopis{at}sina.com Objectives To assess the relative ...
Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut, USA Correspondence to Donna Windish Department of Internal Medicine, Yale Primary Care Residency Program, ...
Correspondence to: Dr Mary Bond PenTAG, Peninsula Medical School, University of Exeter, Veysey Building, Salmon Pool Lane, Exeter EX2 4SG, Devon, UK; mary.bond{at}pms.ac.uk The negative psychological ...
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be ...